Chemical Structure (Nabumetone 01)
Relafen Ds Tablet
Product Images NDC 15370-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Relafen Ds (NDC 15370-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carwin Pharmaceutical Associates, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Nabumetone 02)
Figure (Nabumetone 03)
Principal Display Panel (1,000 mg Tablet Bottle Label)
This is a medication called Relafen DS containing nabumetone. It is available in tablet form with 30 tablets included in a container. It is a prescription-only medication and each tablet contains 1000mg of nabumetone USP. The medication should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) and should be kept out of reach of children. The medication is manufactured by Carwin Pharmaceutical Associates, LLC located in Hazlet, NJ. Please note that a medication guide is provided separately and should be dispensed with this medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
